180 Life Sciences Corp.

NASDAQ: ATNF · Real-Time Price · USD
6.78
-0.83 (-10.91%)
At close: Aug 15, 2025, 1:22 PM

180 Life Sciences Income Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Revenue
n/a n/a n/a n/a
Cost of Revenue
58.28K 105.67K 109K 116.3K
Gross Profit
-58.28K -105.67K -109K -116.3K
Operating Income
-6.32M -13.48M -17.9M -15.64M
Interest Income
n/a n/a 26.67K 186.21K
Pretax Income
-6.46M -22.28M -39.67M -20.35M
Net Income
-6.17M -19.94M -38.73M -20.32M
Selling & General & Admin
4.36M 10.69M 15.47M 11.69M
Research & Development
1.97M 2.78M 2.43M 3.95M
Other Expenses
-58.28K -105.67K n/a n/a
Operating Expenses
6.27M 13.37M 17.9M 15.64M
Interest Expense
50.64K 44.83 26.67K 186.21K
Selling & Marketing Expenses
n/a n/a n/a n/a
Cost & Expenses
6.32M 13.48M 17.9M 15.64M
Income Tax Expense
-296.02K -2.35M 942.75K 23.2K
Shares Outstanding (Basic)
915.37K 379K 100K 82K
Shares Outstanding (Diluted)
915.37K 379.09K 100.02K 82.51K
EPS (Basic)
-15.49 -52.6 -387.26 -247.86
EPS (Diluted)
-15.49 -52.59 -387.18 -246.32
EBITDA
-6.32M -22.13M -17.79M -15.53M
EBIT
-6.51M -22.24M -17.9M -15.64M
Depreciation & Amortization
190.11K 105.67K 109K 109.95K